Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis
Authors
Keywords
-
Journal
BMJ Open
Volume 5, Issue 12, Pages e007133
Publisher
BMJ
Online
2015-12-09
DOI
10.1136/bmjopen-2014-007133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Higher Dosage of Oral Alendronate Will Increase the Subsequent Cancer Risk of Osteoporosis Patients in Taiwan: A Population-Based Cohort Study
- (2013) Wen-Yuan Lee et al. PLoS One
- Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case–control study
- (2013) Juan Erviti et al. BMJ Open
- Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data
- (2013) Y. Vinogradova et al. BMJ-British Medical Journal
- Overlapping meta-analyses on the same topic: survey of published studies
- (2013) K. C. Siontis et al. BMJ-British Medical Journal
- Meta-analysis: oral bisphosphonates and the risk of oesophageal cancer
- (2012) J. Andrici et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Oral Bisphosphonates and Risk of Esophageal Cancer: A Dose-Intensity Analysis in a Nationwide Population
- (2012) Y.-F. Ho et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Oral alendronate use and risk of cancer in postmenopausal women with osteoporosis: A nationwide study
- (2012) Chia-Hung Chiang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies
- (2012) K. Sun et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonates and Risk of Upper Gastrointestinal Cancer — A Case Control Study Using the General Practice Research Database (GPRD)
- (2012) Ellen Wright et al. PLoS One
- Bisphosphonate use and gastrointestinal tract cancer risk: Meta-analysis of observational studies
- (2012) Yun Hwan Oh WORLD JOURNAL OF GASTROENTEROLOGY
- Osteoporosis prescribing trends in primary care: a population-based retrospective cohort study
- (2012) Li Wang et al. Primary Health Care Research and Development
- Occurrence of Gastrointestinal Cancer in Users of Bisphosphonates and Other Antiresorptive Drugs Against Osteoporosis
- (2011) Peter Vestergaard CALCIFIED TISSUE INTERNATIONAL
- Esophageal and gastric cancer incidence and mortality in alendronate users
- (2011) Bo Abrahamsen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Alendronate and Risk of Esophageal Cancer: A Nationwide Population-Based Study in Taiwan
- (2011) Yi-Ming Chen et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Validity of diagnostic coding within the General Practice Research Database: a systematic review
- (2010) Nada F Khan et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Oral Bisphosphonate Prescriptions and the Risk of Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus
- (2010) Dang M. Nguyen et al. DIGESTIVE DISEASES AND SCIENCES
- Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer
- (2010) Chris R. Cardwell et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-term Risks of Bisphosphonates Probed
- (2009) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- More on Reports of Esophageal Cancer with Oral Bisphosphonate Use
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Reports of Esophageal Cancer with Oral Bisphosphonate Use
- (2009) Diane K. Wysowski NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More